Zoetis Inc. Other Nonrecurring Expense
Zoetis Inc. (ZTS) reported Other Nonrecurring Expense of $3.00 million for the 9-month period ending 2015-09-27, per its 10-Q filed 2016-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherNonrecurringExpense · last filed 2016-11-03
- Zoetis Inc. other nonrecurring expense for the quarter ending 2015-09-27 was $0.00.
- Zoetis Inc. other nonrecurring expense for the quarter ending 2015-06-28 was $3.00M.
| Period end | Other Nonrecurring Expense 3 month | Other Nonrecurring Expense 6 month | Other Nonrecurring Expense 9 month |
|---|---|---|---|
| 2015-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $3.00M derived: sum of 2 quarters · filed 2016-11-03 | $3.00M 10-Q · filed 2016-11-03 |
| 2015-06-28 | $3.00M 10-Q · filed 2016-08-05 | $3.00M 10-Q · filed 2016-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |